Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
all 242537 studies found for:    ALL
Show Display Options
Rank Status Study
1 Not yet recruiting Study of Adoptive Cellular Therapy Using Autologous T Cells Transduced With Lentivirus to Express a CD33 Specific Chimeric Antigen Receptor in Patients With Relapsed or Refractory CD33-Positive Acute Myeloid Leukemia
Conditions: Hematopoietic/Lymphoid Cancer;   Acute Myeloid Leukemia
Interventions: Procedure: Leukapheresis;   Drug: Fludarabine;   Drug: Cyclophosphamide;   Biological: CD33-CAR-T Cell Infusion
2 Not yet recruiting Promoting Safe Use of Children's Cough/Cold Medicines
Condition: Cough
Intervention: Other: Label
3 Recruiting Diaphragmatic Dysfunction and Cardiac Surgery; Perioperative Assessment and Effect on Outcome
Condition: Diaphragm Disease
4 Not yet recruiting CLEAR Clinical Study
Condition: Hearing Loss
Interventions: Device: CP910/CP920 with noise reduction on;   Device: CP910/CP920
5 Not yet recruiting Neo-adjuvant Pembrolizumab in Primary Stage IV Ovarian Cancer
Conditions: Ovarian Cancer Stage IV;   Peritoneal Cancer;   Fallopian Tube Cancer
Interventions: Drug: Carboplatin;   Drug: Paclitaxel;   Drug: Pembrolizumab
6 Recruiting A Study of Tarceva vs. Avastin+Tarceva for Advanced NSCLC With EGFR m(+)
Condition: EGFR Positive Non-small Cell Lung Cancer
Interventions: Drug: Erlotinib plus Bevacizumab;   Drug: Erlotinib
7 Not yet recruiting Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Condition: Diabetic Macular Edema
Interventions: Drug: IVT aflibercept + SC CLS-TA;   Drug: IVT Aflibercept + Sham SC
8 Not yet recruiting A Prospective Multicenter Non-interventional Cohort Study on Patients'Satisfaction With Angeliq® Micro in Real Clinical Practice Conducted in Russia
Condition: Menopause
Intervention: Drug: BAY86-4891
9 Recruiting Pilot Study to Assess the Efficacy & Safety of H.P. Acthar® Gel in Subjects With Relapsing-remitting Multiple Sclerosis
Condition: Relapsing, Remitting Multiple Sclerosis
Interventions: Drug: Repository Corticotropin Injection;   Drug: Placebo
10 Not yet recruiting Drug Use Investigation (DUI) of YazFlex for Endometriosis-associated Pelvic Pain and/or Dysmenorrhea
Condition: Endometriosis and Dysmenorrhea
Intervention: Drug: BAY86-5300_YAZ-Flex
11 Completed Effects of Infant Massage on Acceptance, Commitment and Conscience of Influence of Parents With Down Syndrome Babies
Condition: Parent-Child Relations
Intervention: Other: Infant Massage course
12 Recruiting The Study is to Evaluate the Effect of Multiple Doses PF-06751979 on the Pharmacokinetics of Midazolam in Healthy Adults
Condition: Healthy
Interventions: Drug: midazolam;   Drug: PF-06751979
13 Recruiting Cetuximab in Combination With Paclitaxel Plus Cisplatin Versus Paclitaxel Plus Cisplatin Alone for the First-line Treatment of Recurrent and/or Metastatic Esophageal Squamous Cell Carcinoma
Conditions: Esophageal Cancer, Squamous Cell;   Cetuximab Effect;   Chemotherapy Effect
Interventions: Drug: cetuximab;   Drug: cisplatin plus paclitaxel
14 Not yet recruiting A Study to Compare if the Uptake of Ticagrelor in the Body Differs When Different Tablets Are Administered.
Condition: Sickle Cell Disease
Interventions: Drug: Ticagrelor granule;   Drug: Ticagrelor pediatric tablets;   Drug: Ticagrelor pediatric tablets suspended in water;   Drug: Ticagrelor immediate release (IR) tablets (Commercial tablet)
15 Not yet recruiting Effect of Bupropion on Seizure Threshold in Depressed Patients
Condition: MDD
Intervention: Drug: Wellbutrin SR 300Mg Extended-Release Tablet
16 Completed Oxygen as a Limiting Factor for Performing Multitasking
Condition: Cognitive Change
Interventions: Device: Hyperbaric oxygen;   Device: Hyperbaric chamber, normal air
17 Completed Effects of Testosterone on Myocardial Repolarization
Conditions: Hypogonadism;   Chronic Heart Failure
Intervention: Drug: Testosterone Undecanoate
18 Available Expanded Access for Nivolumab (Opdivo)
Condition: Pediatric Cancer
Intervention: Biological: Nivolumab
19 Not yet recruiting Pembrolizumab With or Without Anetumab Ravtansine in Treating Patients With Mesothelin-Positive Pleural Mesothelioma
Conditions: Mesothelin Positive;   Pleural Malignant Mesothelioma
Interventions: Biological: Anetumab Ravtansine;   Other: Laboratory Biomarker Analysis;   Biological: Pembrolizumab;   Other: Pharmacological Study
20 Available Expanded Access to Elotuzumab (Empliciti) for Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Biological: Elotuzumab

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.